Search Result "Psoriasis plaque"


Biologic Therapy in Psoriasis: Safety Profile

Journal: Current Drug Safety
Volume: 11 Issue: 1 Year: 2016 Page: 4-11
Author(s): Anna Campanati, Giulia Ganzetti, K. Giuliodori, Elisa Molinelli, A. Offidani

Anti-Psoriasis Agents from Natural Plant Sources

Journal: Current Medicinal Chemistry
Volume: 23 Issue: 12 Year: 2016 Page: 1250-1267
Author(s): Marco Bonesi,Monica Rosa Loizzo,Eugenio Provenzano,Francesco Menichini,Rosa Tundis

Review Article

Role of IL-17F in the Pathogenesis of Psoriasis

Journal: Current Immunology Reviews (Discontinued)
Volume: 12 Issue: 2 Year: 2016 Page: 112-117
Author(s): Masayuki Nakajima,Mio Kawaguchi,Hideaki Watanabe,Yuko Morishima,Shau-Ku Huang,Hiroaki Satoh,Nobuyuki Hizawa

Proteins Structures in Leishmania Amastigotes for Clinical Remission of Psoriasis

Journal: Current Proteomics
Volume: 13 Issue: 1 Year: 2016 Page: 39-47
Author(s): Jose Antonio O'Daly

Assessment of Possible Drug Interactions in Patients with Psoriasis and Associated Comorbid Medical Conditions: An Observational Study

Journal: Reviews on Recent Clinical Trials
Volume: 11 Issue: 2 Year: 2016 Page: 128-134
Author(s): Reena Sherin, Padmaja Udaykumar

Research Article

New Method of Inhibition of Activity of Tumor Necrosis Factor Alpha In Patients with Psoriasis

Journal: Recent Patents on Endocrine, Metabolic & Immune Drug Discovery
Volume: 10 Issue: 1 Year: 2016 Page: 63-66
Author(s): Borys A. Gerasun

Recent Advances Using Phosphodiesterase 4 (PDE4) Inhibitors to Treat Inflammatory Disorders: Animal and Clinical Studies

Journal: Current Drug Therapy
Volume: 11 Issue: 1 Year: 2016 Page: 21-40
Author(s): Chih-Hung Lin,Shu-Hao Chang,Jia-You Fang

Imiquimod Increases Cutaneous VEGF Expression in Imiquimod-induced Psoriatic Mouse Model

Journal: Current Vascular Pharmacology
Volume: 14 Issue: 3 Year: 2016 Page: 275-279
Author(s): Hui-Hui Wu,Wen-Lin Xie,Yu-Kun Zhao,Juan-Hua Liu,Di-Qing Luo

Therapeutic Targeting of CD6 in Autoimmune Diseases: A Review of Cuban Clinical Studies with the Antibodies IOR-T1 and Itolizumab

Journal: Current Drug Targets
Volume: 17 Issue: 6 Year: 2016 Page: 666-677
Author(s):

Research Article

Silencing the Transcription Factor FOSL1 in Hyperproliferative HaCaT Cells Makes Them Susceptible to IFN-?

Journal: Immunology, Endocrine & Metabolic Agents in Medicinal Chemistry
Volume: 16 Issue: 3 Year: 2016 Page: 199-209
Author(s): Prelovskaya Anna, Mezentsev Alexandre, Piruzian Eleonora, Soboleva Anna, Bruskin Sergey

Previous   Next

Go To   Results 1 - 1 of 32

Filter Result

Volume Year
Content Type
Ads
© 2024 Bentham Science Publishers | Privacy Policy